Ether bond-modified lipid nanoparticles for enhancing the treatment effect of hepatic fibrosis

Jan 17, 2025International journal of pharmaceutics

Lipid nanoparticles with ether bonds to improve treatment of liver scarring

AI simplified

Abstract

LNP-O1 suppressed HSP47 expression by approximately 84% in fibrosis mice, three times more effective than LNP-M.

  • Lipid nanoparticles (LNPs) can deliver RNA for potential liver disease treatments.
  • Incorporating an ether bond into ionizable lipids may enhance delivery efficiency.
  • Three novel ionizable lipids, ND-O1, ND-O2, and ND-O3, were synthesized for this purpose.
  • LNP-O1 showed improved siRNA transfection efficiency in activated fibroblasts compared to LNP-M.
  • LNP-O1 led to a significant reduction in collagen deposition and improvement in liver fibrosis.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free